2003
DOI: 10.1152/ajpheart.00673.2002
|View full text |Cite
|
Sign up to set email alerts
|

Role of paraventricular nucleus in regulation of sympathetic nerve frequency components

Abstract: .-Autospectral and coherence analyses were used to determine the role of and interactions between paraventricular nucleus (PVN) nitric oxide, ␥-aminobutyric acid (GABA), and the N-methyl-D-aspartic acid (NMDA)-glutamate receptor in regulation of sympathetic nerve discharge (SND) frequency components in anesthetized rats. Four observations were made. First, PVN microinjection of bicuculline (BIC) (GABA A receptor antagonist), but not single PVN injections of NMDA (excitatory amino acid) or N G -monomethyl-L-arg… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

8
16
0

Year Published

2006
2006
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(24 citation statements)
references
References 34 publications
8
16
0
Order By: Relevance
“…Conversely, sympathetic or cardiovascular effects seen after microinjection of higher doses of BMI into nearby regions may well be a consequence of exciting neurons in the DMH (see DeNovellis et al, 1995). This would be particularly true in reports that have targeted the PVN with microinjections ranging from 50 pmol to as much as 2 nmol of BMI and assumed that sympathoexcitatory or cardiovascular effects noted were a consequence of disinhibiting neurons in the latter region (Martin et al, 1991;Reynolds et al, 1996;Zhang and Patel, 1998;Kenney et al, 2003;LaGrange et al, 2003;Reddy et al, 2005;Martin et al, 2006). The extent of the region activated by microinjection of 10 pmoles of BMI in this study make it highly plausible that at least some of the changes elicited by microinjection of these larger doses into the nearby PVN may be a consequence of spread or diffusion to the DMH.…”
Section: Discussionmentioning
confidence: 99%
“…Conversely, sympathetic or cardiovascular effects seen after microinjection of higher doses of BMI into nearby regions may well be a consequence of exciting neurons in the DMH (see DeNovellis et al, 1995). This would be particularly true in reports that have targeted the PVN with microinjections ranging from 50 pmol to as much as 2 nmol of BMI and assumed that sympathoexcitatory or cardiovascular effects noted were a consequence of disinhibiting neurons in the latter region (Martin et al, 1991;Reynolds et al, 1996;Zhang and Patel, 1998;Kenney et al, 2003;LaGrange et al, 2003;Reddy et al, 2005;Martin et al, 2006). The extent of the region activated by microinjection of 10 pmoles of BMI in this study make it highly plausible that at least some of the changes elicited by microinjection of these larger doses into the nearby PVN may be a consequence of spread or diffusion to the DMH.…”
Section: Discussionmentioning
confidence: 99%
“…In spite of receiving strong tonic inhibitory input (Chen and Toney 2003b;Chen et al 2003;Kenney et al 2003;Li et al 2006;Martin et al 1991), PVN neurons nevertheless do contribute to ongoing SNA. In anesthetized rats, for example, studies have shown that acute inhibition of PVN neuronal activity or blockade of excitatory inputs reduces ongoing renal SNA (RSNA) (Akine et al 2003;Allen 2002;Stocker et al 2004b, lumbar SNA , and ABP (Akine et al 2003;Allen 2002;Freeman and Brooks 2007;Stocker et al 2004b.…”
Section: Introductionmentioning
confidence: 99%
“…The coordinated actions of excitatory and inhibitory neurotransmitters in the PVN determine the neuronal activity of the PVN. There are complex interactions between specific PVN neurotransmitters for altering sympathetic nerve activity (11,12). Either the increased excitatory stimuli or decreased inhibitory stimuli into the PVN would lead to the increased neuronal activity of the PVN, and consequent increased sympathetic outflow (38,39).…”
mentioning
confidence: 99%